REFERENCES

1. Dieci G, Fiorino G, Castelnuovo M, Teichmann M, Pagano A. The expanding RNA polymerase III transcriptome. Trends Genet 2007;23:614-22.

2. Haurie V, Durrieu-Gaillard S, Dumay-Odelot H, et al. Two isoforms of human RNA polymerase III with specific functions in cell growth and transformation. Proc Natl Acad Sci U S A 2010;107:4176-81.

3. Renaud M, Praz V, Vieu E, et al. Gene duplication and neofunctionalization: POLR3G and POLR3GL. Genome Res 2014;24:37-51.

4. Durrieu-Gaillard S, Dumay-Odelot H, Boldina G, et al. Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elements. Cell Cycle 2018;17:605-15.

5. Van Bortle K, Marciano DP, Liu Q, et al. A cancer-associated RNA polymerase III identity drives robust transcription and expression of SNAR-A noncoding RNA. bioRxiv 2021; doi: 10.1101/2021.04.21.440535.

6. Liu X, Zhang W, Wang H, Lai CH, Xu K, Hu H. Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma. PeerJ 2020;8:e10281.

7. Khattar E, Kumar P, Liu CY, et al. Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression. J Clin Invest 2016;126:4045-60.

8. Wang X, Gerber A, Chen WY, Roeder RG. Functions of paralogous RNA polymerase III subunits POLR3G and POLR3GL in mouse development. Proc Natl Acad Sci U S A 2020;117:15702-11.

9. Wong RC, Pollan S, Fong H, et al. A novel role for an RNA polymerase III subunit POLR3G in regulating pluripotency in human embryonic stem cells. Stem Cells 2011;29:1517-27.

10. Enver T, Soneji S, Joshi C, et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet 2005;14:3129-40.

11. Jin S, Collin J, Zhu L, et al. A novel role for miR-1305 in regulation of pluripotency-differentiation balance, cell cycle, and apoptosis in human pluripotent stem cells. Stem Cells 2016;34:2306-17.

12. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979;17:16-23.

13. Petrie JL, Swan C, Ingram RM, et al. Effects on prostate cancer cells of targeting RNA polymerase III. Nucleic Acids Res 2019;47:3937-56.

14. Wu L, Pan J, Thoroddsen V, et al. Novel small-molecule inhibitors of RNA polymerase III. Eukaryot Cell 2003;2:256-64.

15. Pagano A, Castelnuovo M, Tortelli F, Ferrari R, Dieci G, Cancedda R. New small nuclear RNA gene-like transcriptional units as sources of regulatory transcripts. PLoS Genet 2007;3:e1.

16. Chen CY, Lanz RB, Walkey CJ, Chang WH, Lu W, Johnson DL. Maf1 and repression of RNA polymerase III-mediated transcription drive adipocyte differentiation. Cell Rep 2018;24:1852-64.

17. Deininger P. Alu elements: know the SINEs. Genome Biol 2011;12:236.

18. Hu Q, Tanasa B, Trabucchi M, et al. DICER- and AGO3-dependent generation of retinoic acid-induced DR2 Alu RNAs regulates human stem cell proliferation. Nat Struct Mol Biol 2012;19:1168-75.

19. Morales-Hernández A, González-Rico FJ, Román AC, et al. Alu retrotransposons promote differentiation of human carcinoma cells through the aryl hydrocarbon receptor. Nucleic Acids Res 2016;44:4665-83.

20. Fisher R, Pusztai L, Swanton C. Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer 2013;108:479-85.

21. Ajani JA, Song S, Hochster HS, Steinberg IB. Cancer stem cells: the promise and the potential. Semin Oncol 2015;42 Suppl 1:S3-17.

22. Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell 2014;14:275-91.

23. Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009;347:70-8.

24. Parrott AM, Mathews MB. Novel rapidly evolving hominid RNAs bind nuclear factor 90 and display tissue-restricted distribution. Nucleic Acids Res 2007;35:6249-58.

25. Lee J, Park HY, Kim WW, et al. Biological function of long noncoding RNA snaR in HER2-positive breast cancer cells. Tumour Biol 2017;39:1010428317707374.

26. Huang Y, Hu Y, Jin Z, Shen Z. LncRNA snaR upregulates GRB2-associated binding protein 2 and promotes proliferation of ovarian carcinoma cells. Biochem Biophys Res Commun 2018;503:2028-32.

27. Shi Z, Wei D, Wu H, et al. Long non-coding RNA snaR is involved in the metastasis of liver cancer possibly through TGF-β1. Oncol Lett 2019;17:5565-71.

28. Chen W, Böcker W, Brosius J, Tiedge H. Expression of neural BC200 RNA in human tumours. J Pathol 1997;183:345-51.

29. Iacoangeli A, Lin Y, Morley EJ, et al. BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis 2004;25:2125-33.

30. Singh R, Gupta SC, Peng WX, et al. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis. Cell Death Dis 2016;7:e2262.

31. Samson J, Cronin S, Dean K. BC200 (BCYRN1) - the shortest, long, non-coding RNA associated with cancer. Noncoding RNA Res 2018;3:131-43.

32. Murawski M, Szcześniak B, Zoładek T, Hopper AK, Martin NC, Boguta M. maf1 mutation alters the subcellular localization of the Mod5 protein in yeast. Acta Biochim Pol 1994;41:441-8.

33. Pluta K, Lefebvre O, Martin NC, et al. Maf1p, a negative effector of RNA polymerase III in Saccharomyces cerevisiae. Mol Cell Biol 2001;21:5031-40.

34. Upadhya R, Lee J, Willis IM. Maf1 is an essential mediator of diverse signals that repress RNA polymerase III transcription. Molecular Cell 2002;10:1489-94.

35. Cieśla M, Boguta M. Regulation of RNA polymerase III transcription by Maf1 protein. Acta Biochim Pol 2008;55:215-25.

36. Vorländer MK, Baudin F, Moir RD, et al. Structural basis for RNA polymerase III transcription repression by Maf1. Nat Struct Mol Biol 2020;27:229-32.

37. Vannini A, Ringel R, Kusser AG, Berninghausen O, Kassavetis GA, Cramer P. Molecular basis of RNA polymerase III transcription repression by Maf1. Cell 2010;143:59-70.

38. Kantidakis T, Ramsbottom BA, Birch JL, Dowding SN, White RJ. mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. Proc Natl Acad Sci U S A 2010;107:11823-8.

39. Woiwode A, Johnson SA, Zhong S, et al. PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex. Mol Cell Biol 2008;28:4204-14.

40. Girbig M, Misiaszek AD, Vorländer MK, et al. Cryo-EM structures of human RNA polymerase III in its unbound and transcribing states. Nat Struct Mol Biol 2021;28:210-9.

41. Terry S, Beltran H. The many faces of neuroendocrine differentiation in prostate cancer progression. Front Oncol 2014;4:60.